Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_assertion type Assertion NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_head.
- NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_assertion description "[Adoptive cell transfer (ACT), either using rapidly expanded tumor infiltrating lymphocytes or T-cell receptor transduced peripheral blood lymphocytes, can be considered one of the most promising approaches in cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_provenance.
- NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_assertion evidence source_evidence_literature NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_provenance.
- NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_assertion SIO_000772 20349059 NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_provenance.
- NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_assertion wasDerivedFrom befree-20140225 NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_provenance.
- NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_assertion wasGeneratedBy ECO_0000203 NP853293.RAB7fJeCd21tLJZYQaqL8qsthdE66uvvd_3vawR0QPrMo130_provenance.